OGEN (STOCKS)
Oragenics Inc.
$0.624700
+0.004700 (+0.76%)
Prev close: $0.620000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Janet Huffman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.82M
- Employees
- 5
- P/E (TTM)
- -0.10
- P/B (TTM)
- 0.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2023 (Q2)
|
$-1.51 | $-3.06 | +1.5500 | +50.65% |
|
Mar 2023 (Q1)
|
$-42.30 | $-91.80 | +49.5000 | +53.92% |
|
Mar 2022 (Q4)
|
$-4.50 | $-73.44 | +68.9400 | +93.87% |
|
Sep 2022 (Q3)
|
$-54.00 | $-91.80 | +37.8000 | +41.18% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$394.07K |
| Operating Expenses | $9.59M |
| Research and Development | $2.70M |
| Other Operating Expenses | $6.90M |
| Operating Income/Loss | -$9.59M |
| Income/Loss From Continuing Operations After Tax | -$9.99M |
| Income/Loss From Continuing Operations Before Tax | -$9.99M |
| Net Income/Loss | -$9.83M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.83M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.83M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.97 |
| Diluted Earnings Per Share | -$4.97 |
| Basic Average Shares | 7,286,093 |
| Diluted Average Shares | 7,286,093 |
| Assets | $7.49M |
| Current Assets | $7.49M |
| Noncurrent Assets | $0.00 |
| Liabilities | $1.31M |
| Current Liabilities | $1.31M |
| Noncurrent Liabilities | $0.00 |
| Equity | $6.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.18M |
| Liabilities And Equity | $7.49M |
| Net Cash Flow From Operating Activities | -$9.33M |
| Net Cash Flow From Operating Activities, Continuing | -$9.33M |
| Net Cash Flow From Investing Activities | -$2.69M |
| Net Cash Flow From Investing Activities, Continuing | -$2.69M |
| Net Cash Flow From Financing Activities | $12.02M |
| Net Cash Flow From Financing Activities, Continuing | $12.02M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$9.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.83M |
| Other Comprehensive Income/Loss | $0.00 |